首页> 美国卫生研究院文献>other >Maintaining ocular safety with light exposure focusing on devices for optogenetic stimulation
【2h】

Maintaining ocular safety with light exposure focusing on devices for optogenetic stimulation

机译:通过曝光保持眼睛安全重点是光遗传刺激设备

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Optogenetics methods are rapidly being developed as therapeutic tools for treating neurological diseases, in particular, retinal degenerative diseases. A critical component of the development is testing the safety of the light stimulation used to activate the optogenetic proteins. While the stimulation needs to be sufficient to produce neural responses in the targeted retinal cell class, it also needs to be below photochemical and photothermal limits known to cause ocular damage. The maximal permissible exposure is determined by a variety of factors, including wavelength, exposure duration, visual angle, pupil size, pulse width, pulse pattern, and repetition frequency. In this paper, we develop utilities to systematically and efficiently assess the contributions of these parameters in relation to the limits, following directly from the 2014 American National Standards Institute (ANSI). We also provide an array of stimulus protocols that fall within the bounds of both safety and effectiveness. Additional verification of safety is provided with a case study in rats using one of these protocols.
机译:光学遗传学方法正在迅速发展为用于治疗神经系统疾病,特别是视网膜变性疾病的治疗工具。该开发的关键组成部分是测试用于激活光遗传蛋白的光刺激的安全性。尽管刺激必须足以在目标视网膜细胞类别中产生神经反应,但刺激也必须低于已知会引起眼损伤的光化学和光热极限。最大允许的曝光量由多种因素决定,包括波长,曝光时间,视角,瞳孔大小,脉冲宽度,脉冲图案和重复频率。在本文中,我们直接根据2014年美国国家标准协会(ANSI),开发了实用程序来系统有效地评估这些参数相对于限值的贡献。我们还提供了一系列在安全性和有效性范围内的刺激方案。使用这些方案之一的大鼠案例研究提供了额外的安全性验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号